With regard to these advances in molecular phenotyping, identification of particular histopathological subtypes of lung adenocarcinomas, including bronchioloalveolar pattern or mucinous cribriform pattern, will give important clues for therapeutically tractable genomic changes, such as EGFR gene mutations or EML4-ALK fusion gene. This evidence concerns the gene EML4 and lung adenocarcinoma.